Pages that link to "Q24609914"
Jump to navigation
Jump to search
The following pages link to Linking long-term dietary patterns with gut microbial enterotypes (Q24609914):
Displaying 50 items.
- Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis (Q21128781) (← links)
- Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children (Q21132990) (← links)
- Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans (Q21133618) (← links)
- Divergences in gene repertoire among the reference Prevotella genomes derived from distinct body sites of human (Q21146718) (← links)
- Intestinal microbiota as modulators of the immune system and neuroimmune system: impact on the host health and homeostasis (Q21284481) (← links)
- A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease (Q21559533) (← links)
- Crohn's disease-associated adherent-invasive Escherichia coli adhesion is enhanced by exposure to the ubiquitous dietary polysaccharide maltodextrin (Q21559654) (← links)
- Gut microbiota and metabolic syndrome (Q24563886) (← links)
- The human microbiome: our second genome (Q24601696) (← links)
- Human gut microbiome viewed across age and geography (Q24602950) (← links)
- Molecular diversity of Bacteroidales in fecal and environmental samples and swine-associated subpopulations (Q24623784) (← links)
- Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis (Q24629045) (← links)
- Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease (Q24734938) (← links)
- Systematic review and meta-analysis of lactose digestion, its impact on intolerance and nutritional effects of dairy food restriction in inflammatory bowel diseases (Q26740495) (← links)
- Experimental design considerations in microbiota/inflammation studies (Q26741486) (← links)
- The rise of food allergy: Environmental factors and emerging treatments (Q26744294) (← links)
- The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions (Q26745700) (← links)
- Novel perspectives on therapeutic modulation of the gut microbiota (Q26745706) (← links)
- A healthy gastrointestinal microbiome is dependent on dietary diversity (Q26750607) (← links)
- Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients (Q26750985) (← links)
- Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet (Q26752614) (← links)
- Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health (Q26765857) (← links)
- Probiotics in prevention and treatment of obesity: a critical view (Q26768518) (← links)
- Alcoholic Liver Disease: Update on the Role of Dietary Fat (Q26769970) (← links)
- The First Line of Defense: The Effects of Alcohol on Post-Burn Intestinal Barrier, Immune Cells, and Microbiome (Q26773231) (← links)
- MECHANISMS IN ENDOCRINOLOGY: Metabolic and inflammatory pathways on the pathogenesis of type 2 diabetes (Q26773451) (← links)
- Advances in nutritional therapy in inflammatory bowel diseases: Review (Q26774563) (← links)
- Interaction of Intestinal Microorganisms with the Human Host in the Framework of Autoimmune Diseases (Q26774654) (← links)
- Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont Selection (Q26774688) (← links)
- Diet, Microbiota and Immune System in Type 1 Diabetes Development and Evolution (Q26777399) (← links)
- Medical and alternative therapies in urinary tract stone disease (Q26777616) (← links)
- Enteral feeding and its impact on the gut immune system and intestinal mucosal barrier (Q26777672) (← links)
- Interactions Between the Gastrointestinal Microbiome and Clostridium difficile (Q26778722) (← links)
- Context and the human microbiome (Q26780437) (← links)
- The human gut virome: a multifaceted majority (Q26781401) (← links)
- The gut microbiota and host health: a new clinical frontier (Q26785649) (← links)
- Gut microbiota and allogeneic transplantation (Q26795634) (← links)
- A Review of Applied Aspects of Dealing with Gut Microbiota Impact on Rodent Models (Q26795697) (← links)
- Manipulating the Gut Microbiota: Methods and Challenges (Q26795704) (← links)
- Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design (Q26795715) (← links)
- Intestinal Microbiota and Celiac Disease: Cause, Consequence or Co-Evolution? (Q26796606) (← links)
- Prebiotics and gut microbiota in chickens (Q26799785) (← links)
- Listening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes Pathogenesis (Q26823198) (← links)
- Diet and inflammatory bowel disease: review of patient-targeted recommendations (Q26823435) (← links)
- Modulation of the gut microbiota by nutrients with prebiotic and probiotic properties (Q26823918) (← links)
- The application of ecological theory toward an understanding of the human microbiome (Q26825590) (← links)
- Modeling microbial community structure and functional diversity across time and space (Q26826910) (← links)
- Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena? (Q26828617) (← links)
- Host-microbe interactions shaping the gastrointestinal environment (Q26829479) (← links)
- Mediterranean diet and health: food effects on gut microbiota and disease control (Q26829951) (← links)